Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

Edwards Lifesciences and JenaValve said they remain committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...